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Background and objectives: The use of picosecond lasers to remove tattoos has greatly 
improved due to the long-standing outcomes of nanosecond lasers, both clinically and histo-
logically. The first aesthetic picosecond laser available for this use was the PicoSure® laser 
system (755/532 nm). Now that a vast amount of research on its use has been conducted, we 
performed a comprehensive review of the literature to validate the continued application of the 
PicoSure® laser system for tattoo removal.
Study design and methods: A PubMed search was conducted using the term “picosecond” 
combined with “laser”, “dermatology”, and “laser tattoo removal”.
Results: A total of 13 articles were identified, and ten of these met the inclusion criteria for this 
review. The majority of studies showed that picosecond lasers are an effective and safe treatment 
mode for the removal of tattoo pigments. Several studies also indicated potential novel applica-
tions of picosecond lasers in the removal of various tattoo pigments (eg, black, red, and yellow). 
Adverse effects were generally mild, such as transient hypopigmentation or blister formation, 
and were rarely more serious, such as scarring and/or textural change.
Conclusion: Advancements in laser technologies and their application in cutaneous medicine 
have revolutionized the field of laser surgery. Computational modeling provides evidence that 
the optimal pulse durations for tattoo ink removal are in the picosecond domain. It is recom-
mended that the PicoSure® laser system continue to be used for safe and effective tattoo removal, 
including for red and yellow pigments.
Keywords: tattoo, removal, laser, picosecond
Introduction
The PicoSure® laser is a picosecond laser for aesthetic dermatologic procedures, 
 including laser tattoo removal. Research on laser tattoo removal has now reached a 
critical mass, and there is a large enough body of evidence to discuss the place of 
PicoSure® lasers in this therapy.
In order to appreciate the significant increase in laser tattoo removal in the past 
5 years, it is helpful to understand the brief history of the field.1 Laser tattoo removal 
began in the early 1960s with the use of argon and CO
2
 lasers.2 The nonselective nature 
of these lasers led to significant side effects, such as scarring and  hypopigmentation. 
Advancements in laser technology in the 1980s led to more selective pigment 
 targeting with quality-switched (Q-switched) lasers.2–4 From that time period up to 
the present day, nanosecond-pulse-duration lasers have been the mainstays of care 
in the management of laser tattoo removal. The newest development in the field is 
that of picosecond pulse durations, which may result in even finer pigment targeting. 
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Both nanosecond- and picosecond-pulse-duration lasers are 
 currently heavily  utilized standards of care.
Since 1983, Anderson and Parrish’s concept of selective 
photothermolysis has provided the basis for the effectiveness 
of picosecond pulse durations for selective pigment  targeting.5 
Their theory is based on the concept that a chromophore 
within the skin can be targeted without collateral damage, 
by manipulating absorption and pulse duration to less than or 
equal to the thermal relaxation time (TRT). The TRT is defined 
as the square of the diameter of the target chromophore in 
millimeters. As such, their work indicates that the TRT of pig-
ments treated with picosecond lasers may be optimal for mini-
mizing collateral damage to nontargeted areas. This was tested 
by Ho et al with computer simulations, utilizing graphite ink 
particle size as the standard of study (range: 10 nm–5 µm).6 
From the simulation, the optimal pulse duration for tattoo 
removal ranges from 10 to100 picoseconds, based upon the 
assumption that the pulse should be less than or equal to the 
TRT, as well as long enough to overcome the  tensile strength 
of the object. Thus, compared with nano second pulse dura-
tions, picosecond lasers are likely to provide fewer adverse 
effects, such as scarring and/or hypopigmentation, due to 
reduced nonspecific targeting.
Although the simulated test of picosecond lasers for 
tattoo removal did not occur until 2002, they have been 
utilized for this purpose since the 1990s.2–4,7 Investigators 
have conducted comparative studies between picosecond 
and nanosecond therapies to determine the most efficient 
and safe approach.7,8 The PicoSure® laser system is one such 
picosecond laser that utilizes the specifications of 755 nm 
wavelength with optional 532 nm wavelength; pulse dura-
tion of 550–750 picoseconds; energy of 165–200 mJ; and 
spot size ranging from 2 to 6 mm.9 The following review 
analyzes the available current evidence to elucidate the 
recommended future use of the PicoSure® laser system for 
laser tattoo removal.
Methods
A review of literature on PubMed pertaining to  picosecond 
laser use in laser tattoo removal was performed for the 
period from May 2015 to August 2015. The following 
terms were searched: “picosecond” combined with “laser”, 
“ dermatology”, and “laser tattoo removal”. Inclusion criteria 
were as follows: 1) the article is a case study, review of lit-
erature, case report, or commentary; and 2) picosecond laser 
tattoo removal was used or discussed in the article. Exclusion 
criteria were non-English articles and those that did not utilize 
 picosecond laser as the primary mode of tattoo removal.
Results
The PubMed search for “picosecond” yielded 4,432 articles. 
Combining “picosecond” with the specific search terms 
yielded more focused articles, which included “picosecond 
laser” (1,691), “picosecond laser tattoo” (13), “picosecond 
laser tattoo removal” (ten), and “picosecond laser tattoo 
removal dermatology” (eight). Eleven articles met the inclu-
sion criteria and were reviewed for their insights on picosec-
ond laser tattoo removal (Table 1). Eight of these represent 
studies that listed the laser parameters investigated.7,8,10–15
Ross et al7 evaluated the effectiveness of picosecond 
versus nanosecond Q-switched Nd:YAG (neodymium-
doped yttrium aluminium garnet) lasers in terms of tattoo 
pigment removal in 16 patients. Each patient received four 
treatments at 4-week intervals under both pulse durations. 
The tattoo was split into three sections for comparison of 
efficacy and one control treatment section. The settings for 
Nd:YAG  picosecond domain laser (Model YG501;  Quantel 
 Technologies, Santa Clara, CA, USA) treatment were a flu-
ence of 0.65 J/cm2, spot size of 1.4 mm, and pulse duration 
of 35 picoseconds. Alternatively, the settings for Nd:YAG 
picosecond domain laser (Model NY82-10, Continuum, 
Santa Clara, CA, USA) treatment were a fluence of 0.65 J/
cm2, spot size of 1.4 mm, and pulse duration of 10 nanosec-
onds. On blinded evaluation, there was significant lightening 
with picosecond lasers, compared with nanosecond lasers, 
in 12 of 16 patients with treated tattoos.7
Herd et al8 performed a comparative split-tattoo study 
of picosecond titanium:sapphire (795 nm) laser versus 
Q-switched alexandrite (752 nm) laser for tattoo removal in 
an animal model (albino guinea pigs). The fluences utilized 
for the picosecond and nanosecond domain lasers were 6.11, 
4.24, and 2.39 J/cm2, with respective spot sizes of 1.25, 1.5, 
and 2 mm. Greater clearance of tattoo pigment was seen in 
the titanium:sapphire picosecond laser-treated areas in two of 
four surviving guinea pigs. The histologic clearance mirrored 
the results of clinical clearance, and the increased fluence 
led to greater pigment  clearance.8  Izikson et al10 compared 
a novel 758 nm alexandrite 500 picoseconds laser with a 
Q-switched alexandrite laser for treating black carbon tattoos 
in an animal model ( Yorkshire pig). The 758 nm picosecond 
laser was used in three settings to produce tissue whitening: 
high (13–16 J/cm2, 1.3 mm spot size), medium (6–7.5 J/cm2, 
1.9 mm spot size), and low (2.5–3.9 J/cm2, 2.9 mm spot size). 
A fluence of 8 J/cm2, spot size of 3 mm, and pulse duration 
between 30 and 50 was used for the 755 nm Q-switched 
alexandrite laser. After a single treatment, the 758 nm 
500 picoseconds laser produced greater tattoo clearance at all 
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Table 1 Clinical studies of picosecond laser tattoo removal and novel dermatologic uses
Author(s) Year Design Number 
and type  
of subject
Pigment color or 
target
Clinical end points and  
patient satisfaction
Adverse effects
Ross et al6 1998 intratattoo  
comparison study
16 patients eleven multicolored  
(black, red, and green);  
five black only
12/16 tattoos with PS showed  
significantly more lightening  
than NS
Pinpoint bleeding, edema, 
hypopigmentation, scarring 
in NS
Herd et al7 1999 Controlled  
comparison study
Six albino 
guinea pigs
Black Greater tattoo clearance within  
PS-treated areas in two of four  
surviving guinea pigs (three spots  
almost total clearance) than NS
None
Ho et al5 2002 Computer modeling N/A Black (graphite tattoo) Tattoo clearance in 17 patients N/A
Choudhary3 2010 Literature review N/A N/A PS identified as the newest  
development
N/A
izikson et al9 2010 Comparison study Two adult 
female pigs
india ink and iron  
oxide
All sites greater pigment lightening  
with PS compared to Q-switched  
alexandrite (not significant)- 
blinded scoring
None
Brauer et al10 2012 Case series Ten  
patients
Blue and green  
pigment
11/12 tattoos 75% clearance at  
1-month follow-up; 12th tattoo  
required two treatments
Pain (mean pain score for 
treatment: –1.08 on ten-point 
scale)
Saedi et al11 2012 Prospective trial 15 patients Black and blue 12/15 patients had .75%  
clearance in one to two  
treatments; three had 75%  
in three to four treatments;  
all 12 patients completed study;  
100% satisfaction
Pain (mean pain score: 4.5/10), 
swelling, postinflammatory 
hypopigmentation in three 
of 15, postinflammatory 
hyperpigmentation in two 
of 15, blistering
Alabdulrazzaq  
et al13
2015 Case series Six patients Multicolored tattoos  
that contain yellow  
pigment
One subject complete clearance  
in one treatment; five subjects  
two to four treatments to  
achieve 75% clearance
Pain (mean pain score: 1.3/10), 
edema, erythema, pain, blisters 
(in three of six), transient 
hypopigmentation (one of six)
Ho et al4 2015 Literature review N/A N/A N/A N/A
Au et al12 2015 Randomized 
controlled trial
26 patients 80% blue-black tattoos 81 patients treated with  
picosecond plus AFR did not  
experience blistering vs 26 PS  
alone (statistically significant)
81/95 patients blistered after 
PS alone; six of 81 did not 
blister after PS plus AFR
Bernstein  
et al14
2015 Prospective clinical 
study
21 patients Black (31), green (eight),  
red (six), blue (two),  
purple (two), yellow (two)
Overall average clearance 79% in  
average 6.5 treatments
edema, erythema; rarely 
transient pigment alteration
Abbreviations: AFR, ablative fractional resurfacing (CO2 laser); NS, nanosecond laser; PS, picosecond laser; N/A, not applicable.
the tested fluencies than the Q-switched alexandrite 755 nm 
laser.10 In a series of cases, Brauer et al11 investigated blue 
and green tattoo pigment removal with a novel picosecond 
laser. Ten patients representing 12 blue and/or green tattoos 
were treated with a 755 nm alexandrite laser (Cynosure®). The 
settings used in the study were fluences of 2.0–2.83 J/cm2, 
with 750–900 picoseconds pulse durations and respective 
spot sizes of 3.0–2.6 mm. At 1-month follow-up, eleven of 
12 treated tattoos showed .75% clearance with one to two 
treatments. Additionally, two-thirds of the blue-green tattoos 
approached 100% clearance after treatment.11 In a prospec-
tive trial by Saedi et al,12 the efficacy of picosecond 755 nm 
alexandrite laser (Cynosure®)for tattoo pigment removal 
was evaluated. Twelve patients completed the study. The 
settings utilized were fluence range of 2.1–4.1 J/cm2, spot 
size of 2.5–3.5 mm, and pulse duration of 500–900 pico-
seconds. Blinded physician evaluation demonstrated that 
all 12 patients had a .75% tattoo clearance rate over an 
average of 4.25 treatments. Nine patients achieved the 75% 
clearance threshold after two to four treatments. Upon fill-
ing out a satisfaction survey, all patients were identified 
as  satisfied or extremely satisfied with the treatment.12 Au 
et al13 retrospectively investigated the incidence of bulla 
after tattoo treatment. Eighty-one patients were treated with 
picosecond domain alexandrite laser alone, and an additional 
20 patients were treated with a combination laser therapy of 
fractionated CO
2
 ablation. The settings used for the picosec-
ond domain alexandrite laser alone (PicoSure®; Cynosure, 
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Inc, Westford, MA, USA) were fluences of 3.09–3.37 J/cm2 
and spot sizes of 2.94–2.95 mm. The combination therapy 
of picosecond/ablative fractional resurfacing (AFR) (Fraxel 
Re:pair; Solta Medical, Inc., Hayward, CA, USA, and 
 AcuPulse; Lumenis Ltd., Yokneam, Israel) used a fluence 
of 2.67 J/cm2 (picosecond), energy of 10–60 mJ (15%–40% 
coverage; Fraxel Re:pair), and energy of 10–20 mJ (5% 
coverage; AcuPulse). Bullae formed in 26 patients treated 
with the picosecond laser alone. In comparison, none of 
the combination therapy (picosecond/AFR)-treated tattoos 
developed blistering.13 Alabdulrazzaq et al14 evaluated the 
use of a novel 532 nm picosecond laser for the clearance of 
 yellow tattoo ink. The case series consisted of six subjects 
with multicolored tattoos that contained yellow  pigment. 
Laser settings used for the Nd:YAG 532 nm laser were a 
fluence range of 1.1–1.4 J/cm2, spot size of 2.5–3.3 mm, and 
pulse duration of 450–500 picoseconds. Treatment intervals 
ranged from 6 to 8 weeks, with one patient achieving com-
plete clearance in a single treatment. All others achieved 75% 
clearance in two to four treatments.14 Bernstein et al15 tested 
the use of a Nd:YAG picosecond domain laser in multicolor 
tattoo removal. It was used on 21 subjects, representing 31 
tattoos treated. The settings used for the frequency-doubled 
picosecond-domain laser (PicoWay®; Syneron Candela 
Corp, Wayland, MA, USA) were fluence of 11 J/cm2 for 
1,064 nm and 5.5 J/cm2 for 532 nm; spot size of 3–5 mm; and 
pulse duration between 350 and 450 picoseconds (532 and 
1,064 nm, respectively). Blinded-scaled evaluation showed 
an average 79% clearance score after 6.5 treatments. Tattoo 
pigment clearance varied by color, with black and purple 
showing most improvement with 1,064 nm after seven 
treatments. Yellow and red pigments exhibited the highest 
clearance score of 85% and 80%, respectively, with 532 nm 
wavelength after seven treatments.15
Discussion
With the rapid increase in tattooing, there has been a parallel 
increase in demand for removal.4 This has spurred significant 
growth in the application of laser tattoo removal. For many 
years, the standard of care was Q-switched lasers with nano-
second pulse durations, but the literature now suggests that 
picosecond lasers may be a more effective therapy. In com-
parison to nanosecond lasers, clinical results from picosecond 
lasers have demonstrated better tattoo pigment clearance and 
a reduction in side effects. Initial work by Ross et al7 identi-
fied that picosecond pulse durations can lead to significantly 
better whitening compared to nanosecond pulse durations, in 
addition to the need for fewer treatments, with comparable 
side effects.7 While the mechanism behind picosecond pulse 
duration laser’s removal of tattoos has not been  definitively 
elucidated, it is postulated that  photomechanical and 
 thermal damage to the tattoo ink leads to elimination either 
 transepidermally and/or by macrophage  rephagocytosis.8 It 
has been suggested that the improved efficiency compared 
with nanosecond lasers observed by those like Ross et al7 
is due to the better matching of the pulse duration, less 
than or equal to the TRT of the chromophore (diameter 
dependent).5–8,10,16 Standard estimations of tattoo particles 
are 0.1 µm, resulting in a TRT in the picosecond duration.6 
PicoSure® is one such laser with current specifications of 
755 nm wavelength plus an optional 532 nm wavelength; 
pulse durations of 550–750 picoseconds; energy of 165–
200 mJ; and spot size range of 2–6 mm.9 Recent studies have 
supported this line of thinking.9,12
Regarding potential side effects, it is important to point 
out that picosecond pulse durations allow for inertial con-
finement, whereby thermal and photomechanical damage 
are confined to the particle.8 Thus, tattoo ink particles can 
be damaged while the surrounding tissue is not. In addi-
tion, picosecond lasers allow for more concentrated energy 
delivery. As a result, picosecond lasers allow the use of lower 
treatment fluences.8,12 This reduction in treatment fluences 
decreases adverse side effects, such as posttreatment pigment 
alteration or scarring. Contrarily, because of their longer 
wavelength, nanosecond pulse duration lasers allow for the 
diffusion of thermal and photomechanical (acoustic) shock-
waves to the surrounding tissue.6,8,12 Adverse events such as 
scarring were not reported in any clinical study evaluated, 
but postinflammatory pigment alteration was evident in some 
patients who received treatment with picosecond lasers.
Perhaps this reduced likelihood of adverse side effects 
plays a role in patient satisfaction with picosecond lasers. 
In one study, patients rated treatment satisfaction as high, 
which was also correlated with clearance.12
Conclusion
Tattoo removal by laser systems is an evolving field that has 
experienced recent major advances in the use of picosecond 
lasers, including the introduction of the PicoSure® laser. In 
the few comparison studies available, picosecond lasers are 
most effective, requiring less treatments and lower fluences 
than nanosecond lasers.7,8 In addition, when measured, 
patient satisfaction has been rated highly by the patients. 
Hence, although Q-switched lasers using nanosecond pulses 
have been stalwarts in laser tattoo removal since the 1980s, 
recent technological advancements in picosecond lasers 
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have revolutionized the field.12 Multiple recent studies have 
strengthened the argument for using picosecond pulse dura-
tion lasers for the removal of tattoos. Picosecond lasers are 
a safe and efficient therapy model for removal of tattoo pig-
ments, most notably in darkly pigmented tattoos.
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